Bank Of America Corp Belite Bio, Inc Transaction History

Bank Of America Corp

$1.17 Trillion
Q4 2024

A detailed history of Bank Of America Corp transactions in Belite Bio, Inc stock. As of the latest transaction made, Bank Of America Corp holds 18,342 shares of BLTE stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,342

Previous 13,451 36.36%

Holding current value

$1.25 Million

Previous $630,000 83.65%

% of portfolio

0.0%

Previous 0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$46.52 - $83.84 $227,529 - $410,061	4,891 Added 36.36%	18,342 $1.16 Million
Q3 2024 Nov 14, 2024	BUY	$44.57 - $50.36 $594,964 - $672,255	13,349 Added 13087.25%	13,451 $630,000
Q2 2024 Aug 14, 2024	SELL	$32.33 - $50.1 $52,439 - $81,262	-1,622 Reduced 94.08%	102 $4,000
Q1 2024 May 15, 2024	SELL	$37.81 - $48.01 $18,224 - $23,140	-482 Reduced 21.85%	1,724 $66,000
Q4 2023 Feb 14, 2024	BUY	$29.5 - $46.02 $65,077 - $101,520	2,206 New	2,206 $100,000

About BELITE BIO, INC

Ticker BLTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,867,400
Market Cap $1.7B
Description
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...

More about BLTE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Belite Bio, Inc Transaction History